RxSight, Inc.
Health
Performance
9.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

RxSight, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

23.12.2025
Momentum tanked. Clearly underperforming.
10.12.2025
Red alert. Risk levels out of control.

RxSight, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does RxSight, Inc. do? Business model and key facts

Get the full picture of RxSight, Inc.: what it builds, where it operates, and how it makes money.

RxSight, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 498

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

shop
Company facts
Ronald Kurtz
CEO
498
Employees worldwide
shop
Performance
-68.74%
Last 12 months
-38.81%
Last 5 years
shop
Growth
$139,93M
Revenue year
$-27.455.000
Net income
shop
Valuation
$403,35M
Market Cap
-48.67
Price/Earnings Ratio

Stocks related to RxSight, Inc.

Selected based on industry alignment and relative market positioning.

KIDS
OrthoPediatrics Corp.
18.35
-1.92%
6.7
Sell
Buy
OrthoPediatrics Corp.
CERS
Cerus Corporation
2.60
-5.11%
7.8
Sell
Buy
Cerus Corporation
BVS
Bioventus Inc.
7.93
-0.75%
6.1
Sell
Buy
Bioventus Inc.
QTRX
Quanterix Corporation
7.40
-6.92%
8.2
Sell
Buy
Quanterix Corporation
VMD
Viemed Healthcare, Inc.
7.33
-2.79%
5.7
Sell
Buy
Viemed Healthcare, Inc.

RxSight, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.